Pharma stocks in good health … expects uptrends continues – Just read
Pharma stocks gained 20-40% in the last few sessions after the government approved exports of hydroxychloroquine to US.
Market hope that it may positive for Indian Pharma players in future for benefitting of US FDA approval on other medicines. Let see that the last couple of days, many Indian pharma got US FDA approval (sell below). Indian Pharma players have huge pipe line from US FDA for approval on their products. Expectation is that they may get positive answer from US FDA very soon – We sare positive for Sun Pharma, Strides, Divi’s, Biocon, Lupin, Cipla, Ajanta, Alkem Labs
Last two days US FDA approval
· Cipla : Company gets US FDA approval of generic version of proventtihfa inhalation Afrosol. – Yesterday
· Ajanta Pharma gets USFDA nod for Parkinson's disease tablet – Yesterday
· Lupin –Company launched generic mycophenolic acid delayed-release tablets in the US market – Tuesday
· CADILA gets US FDA approval for Imatinib Mesylate pills - Today
· Granules India announced today that the US FDA has approved the ANDA filed by Granules Pharmaceuticals, Inc (GPI)., a wholly owned foreign subsidiary of Granules India - Today
· Cipla as US FDA Approves Bronchospasm Drug – Yesterday
